|
71 |
Addressing Domain Specificity in the Development of a Cell-Based Binding Assay for the Detection of Neutralizing Antibodies Against a CD47xPD-L1 Bispecific Antibody
Enthalten in American Association of Pharmaceutical Scientists: The AAPS journal Bd. 25, 22.9.2023, Nr. 6, date:11.2023: 1-10
|
|
|
|
72 |
Antibody–drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry
Enthalten in Archives of pharmacal research Bd. 46, 6.3.2023, Nr. 3, date:3.2023: 131-148
|
|
|
|
73 |
Author Correction: Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies
Enthalten in Scientific reports Bd. 15, 28.4.2025, Nr. 1, date:12.2025: 1
|
|
|
|
74 |
Beyond Bruton’s tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody–drug conjugates, CAR T-cells, and novel agents
Enthalten in Journal of hematology & oncology Bd. 16, 25.8.2023, Nr. 1, date:12.2023: 1-26
|
|
|
|
75 |
Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
Enthalten in Molecular medicine Bd. 24, 24.9.2018, Nr. 1, date:12.2018: 1-15
|
|
|
|
76 |
Bispecific and multispecific antibodies in oncology: opportunities and challenges
Enthalten in Nature reviews / Clinical oncology Bd. 21, 31.5.2024, Nr. 7, date:7.2024: 539-560
|
|
|
|
77 |
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
Enthalten in Blood cancer journal Bd. 14, 8.2.2024, Nr. 1, date:12.2024: 1-10
|
|
|
|
78 |
Bispecific antibodies and CLEM: an analytical approach to advanced cell imaging for therapeutic strategies
Enthalten in Applied microscopy Bd. 55, 20.1.2025, Nr. 1, date:12.2025: 1-7
|
|
|
|
79 |
Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting
Enthalten in Experimental hematology & oncology Bd. 12, 26.8.2023, Nr. 1, date:12.2023: 1-3
|
|
|
|
80 |
Bispecific antibodies as monotherapy or in combinations for non-hodgkin B-cell lymphoma: latest updates from the American society of hematology 2022 annual meeting
Enthalten in Experimental hematology & oncology Bd. 12, 21.4.2023, Nr. 1, date:12.2023: 1-4
|
|
Administration
